Inference from a multiplicative model of joint genetic effects or ovarian cancer risk

Journal of the National Cancer Institute

Volumn 103, Issue 2, 2011, Pages 82-83

  Wacholder, Sholom ^a   Han, Summer S ^a   Weinberg, Clarice R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; TAMOXIFEN;

BREAST CANCER; CANCER RISK; CHROMOSOME 9P; EDITORIAL; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MATHEMATICAL MODEL; MULTIPLICATIVE MODEL; OVARY CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENES, BRCA1; GENES, BRCA2; GENOTYPE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MODELS, STATISTICAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79251496404     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq510     Document Type: Editorial

References (11)

1. Ramus SJ, Kartsonaki C, Gayther SA, et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2010; 103 ( 2 ): 105-116 .
2. Song H, Ramus SJ, Tyrer J, et al. A genome-wide association study iden-tifi es a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet. 2009; 41 ( 9 ): 996-1000 .
3. Satagopan JM, Offi t K, Foulkes W, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2001; 10 ( 5 ): 467-473 .
4. Satagopan JM, Boyd J, Kauff ND, et al. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clin Cancer Res. 2002; 8 ( 12 ): 3776-3781 .
5. Modan B, Hartge P, Hirsh-Yechezkel G, et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation 750. N Engl J Med. 2001; 345 ( 4 ): 235-240 .
6. Weinberg CR. Applicability of the simple independent action model to epidemiologic studies involving 2 factors and a dichotomous outcome 7. Am J Epidemiol. 1986; 123 ( 1 ): 162-173 .
7. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005; 366 ( 9486 ): 649-659 .
8. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifi es multiple susceptibility loci. Nat Genet. 2010; 42 ( 11 ): 978-984 .
9. Brown CC, Chu KC. Additive and multiplicative models and multistage carcinogenesis theory. Risk Anal. 1989; 9 ( 1 ): 99-105 .
10. Siemiatycki J, Thomas DC. Biological models and statistical interactions: an example from multistage carcinogenesis. Int J Epidemiol. 1981; 10 : 383-387 .
11. Rothman KJ, Greenland S, Lash TL. Concepts of interaction. In: Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, PA : Lippincott Williams & Wilkins; 2008 : 71-83 .